BerGenBio ASA Sustainability Reports
Bergenbio ASA is a clinical-stage biopharmaceutical company focused on developing innovative drugs to treat aggressive cancers and severe respiratory diseases.
Sector: Health Care
Country: Norway
Exchange: Oslo Bors
ISIN: NO0010650013
11 reports from 2015 to 2024
Company Profile
BerGenBio ASA
Bergenbio ASA is a clinical-stage biopharmaceutical company focused on developing innovative drugs to treat aggressive cancers and severe respiratory diseases.
Reports